BALAXI PHARMACEUTICALS
|
The Current P/E Ratio of BALAXI PHARMACEUTICALS is 12.16.
Share Price | ₹60.3 | Apr 24,2025 |
Market Cap | ₹332.7 Cr | |
Earnings-TTM | ₹27.4 Cr | TTM-Consolidated Results |
Price/Earnings | 12.16x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of BALAXI PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹332.7 Cr] as on Apr 24,2025
(/) Earnings [ ₹27.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 12.16x ]
Thus, for BALAXI PHARMACEUTICALS , the investors are currently willing to pay 12.16 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BALAXI PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BALAXI PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of BALAXI PHARMACEUTICALS
PE Ratio Performance Analysis for BALAXI PHARMACEUTICALS
- BALAXI PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 7.11x.
- BALAXI PHARMACEUTICALS 's operated at median p/e ratio of 7.3x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BALAXI PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 14.09x.
- BALAXI PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does BALAXI PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?
Peer Comparison (Trading Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
BALAXI PHARMACEUTICALS | 27.36 | 12.16 | 332.7 |
ADANI ENTERPRISES LTD | 3,799.73 | 74.16 | 281,799.0 |
REDINGTON LTD | 1,226.77 | 15.62 | 19,157.4 |
MMTC LTD | 101.03 | 92.05 | 9,300.0 |
HONASA CONSUMER LTD | 78.18 | 98.82 | 7,726.4 |
LLOYDS ENTERPRISES LTD | 151.82 | 46.03 | 6,987.8 |
ENTERO HEALTHCARE SOLUTIONS LTD | 97.19 | 60.02 | 5,833.3 |
OPTIEMUS INFRACOM LTD | 57.53 | 79.00 | 4,544.6 |
POLO QUEEN INDUSTRIAL & FINTECH LTD | 3.41 | 794.86 | 2,712.9 |
MSTC LTD | 408.19 | 9.46 | 3,861.4 |
SG MART LTD | 103.81 | 38.64 | 4,010.9 |
Trading Industry Benchmark (Top 10) PE Analysis vs BALAXI PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 9.46x |
Max industry PE | 794.86x |
Median industry PE | 60.02x |
Average industry PE | 120.07x |
You may also like the below Video Courses